NCT05244564

Brief Summary

This is a prospective randomized controlled trial comparing two ways of delivering Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) therapy for posttraumatic stress disorder (PTSD). The study seeks 60 volunteers who have PTSD and are eligible for care in the Department of Defense healthcare system. There will be 10-14 therapy sessions that are 60-90 minutes long, about once a week, and symptoms will be assessed before and after the therapy as well as 3 and 6 months after completing therapy. 3MDR asks you to choose pictures and music that are integrated into a virtual reality environment. You will be walking on a treadmill throughout each therapy session, while the therapist stands next to the treadmill and asks you questions about the pictures you chose.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
18mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Apr 2023Oct 2027

First Submitted

Initial submission to the registry

August 11, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 17, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 30, 2023

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2027

Last Updated

July 15, 2025

Status Verified

July 1, 2025

Enrollment Period

4.1 years

First QC Date

August 11, 2021

Last Update Submit

July 14, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinician Administered PTSD scale for DSM5 (CAPS-5)

    The primary outcome measure will be the Clinician Administered PTSD scale for DSM5 (CAPS-5), the gold standard measure for PTSD diagnosis, to assess PTSD symptom severity.

    3 months

  • PTSD Checklist for DSM5 (PCL5)

    The PTSD Checklist for DSM5 (PCL5), a well-validated 20-item self-report measure of PTSD symptom severity.

    3 months

Secondary Outcomes (4)

  • Patient Health Questionnaire Depression module (PHQ-9)

    3 months

  • Insomnia Severity Index (ISI)

    3 months

  • Neurobehavioral Symptom Inventory (NSI)

    3 months

  • Brief Resilience Scale (BRS)

    3 months

Study Arms (2)

3MDR delivered via Augmented Reality Head Mounted Display

EXPERIMENTAL

All participants will complete 10-14 treatment sessions (three preparatory sessions, 6 to 10 3MDR therapy sessions, and one concluding session), led by a therapist who has completed training and/or is experienced in the conduct of this form of therapy.

Other: Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR)

3MDR delivered via 34-inch curved screen high definition gaming computer monitor

ACTIVE COMPARATOR

All participants will complete 10-14 treatment sessions (three preparatory sessions, 6 to 10 3MDR therapy sessions, and one concluding session), led by a therapist who has completed training and/or is experienced in the conduct of this form of therapy.

Other: Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR)

Interventions

"Walk and talk" therapy, walking on a treadmill while talking with a therapist about self-chosen pictures representative of one's trauma; 3MDR also includes some features of virtual reality exposure therapy (VRET) and Eye Movement Desensitization and Reprocessing (EMDR) therapy.

3MDR delivered via 34-inch curved screen high definition gaming computer monitor3MDR delivered via Augmented Reality Head Mounted Display

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Service member, veteran, retiree, or DEERS-eligible dependent, male or female, at least 18 years or older
  • Diagnosis of PTSD, as confirmed by the CAPS-5
  • Able to ambulate with contact guard assistance or less, and walk unassisted on a treadmill, at a normal pace, for up to 90 minutes continuously

You may not qualify if:

  • History of epilepsy or a seizure disorder, other than febrile seizures that occurred during childhood and have not recurred since
  • History of a psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation
  • Use of benzodiazepines on a regular basis within the previous 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uniformed Services University

Bethesda, Maryland, 20814, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Michael Roy, MD, MPH

    Unformed Services University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hannah Attalah, BA

CONTACT

Michael Roy, MD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All receive the 3MDR intervention, but are randomized to delivery via AR HMD vs via curved high definition gaming computer monitor
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

August 11, 2021

First Posted

February 17, 2022

Study Start

April 30, 2023

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

October 30, 2027

Last Updated

July 15, 2025

Record last verified: 2025-07

Locations